Metlife (MET) closed at $100.02 on October 30, 2026, down 0.8% from the previous close, on volume of 3,537,720 shares (30-day average 3,141,318).
Data as of October 30, 2026.
30-Oct-2026
Financials Q3 earnings roundup: Payment giants lead a week of EPS beats
Seeking Alpha News (Fri, 30-Oct 10:20 AM ET)
MetLife CEO and CFO to Speak at the J.P. Morgan Financials Conference
Business Wire (Thu, 29-Oct 4:15 PM ET)
Bill Ackman calls Meta 'incredibly undervalued,' says it can afford AI spending
Seeking Alpha News (Thu, 29-Oct 2:15 AM ET)
Anthropic’s $131.7B war chest trails only Berkshire Hathaway, Alphabet
Seeking Alpha News (Wed, 28-Oct 11:29 AM ET)
Business Wire (Wed, 14-Oct 8:00 AM ET)
MetLife to Announce Third Quarter 2026 Results
Business Wire (Wed, 7-Oct 4:15 PM ET)
Business Wire (Wed, 7-Oct 9:30 AM ET)
MetLife Declares Fourth Quarter 2026 Common Stock Dividend
Business Wire (Tue, 6-Oct 4:15 PM ET)
PRNewswire (Tue, 6-Oct 9:09 AM ET)
MetLife Investment Management Closes Galaxy 38 CLO
Business Wire (Wed, 16-Sep 8:30 AM ET)
MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: group benefits, retirement and income solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Investment Managenent. Group Benefits and RIS are US-based, contributing to around 52% of the firm's 2025 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 14% of 2024 earnings. The EMEA and investment management segments contributed around 6% and 3% of 2025 earnings, respectively.
Metlife trades on the NYSE stock market under the symbol MET.
As of October 30, 2026, MET stock price declined to $100.02 with 3,537,720 million shares trading.
MET has a beta of 0.73, meaning it tends to be less sensitive to market movements. MET has a correlation of 0.16 to the broad based SPY ETF.
MET has a market cap of $63.56 billion. This is considered a Large Cap stock.
Last quarter Metlife reported $19 billion in Revenue and $2.43 earnings per share. This fell short of revenue expectation by $-563 million and exceeded earnings estimates by $.06.
In the last 3 years, MET traded as high as $103.65 and as low as $58.89.
The top ETF exchange traded funds that MET belongs to (by Net Assets): VTI, VOO, VO, IVV, SPY.
MET has outperformed the market in the last year with a price return of +29.3% while the SPY ETF gained +12.3%. MET has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +3.6% and -0.7%, respectively, while the SPY returned +2.1% and -1.0%, respectively.
MET support price is $99.25 and resistance is $102.41 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MET shares will trade within this expected range on the day.
